Skip to main content
Log in

How to interpret multidimensional quality of life questionnaires for patients with schizophrenia?

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Purpose

The classification of patients into distinct categories of quality of life (QoL) levels may be useful for clinicians to interpret QoL scores from multidimensional questionnaires. The aim of this study had been to define clusters of QoL levels from a specific multidimensional questionnaire (SQoL18) for patients with schizophrenia by using a new method of interpretable clustering and to test its validity regarding socio-demographic, clinical, and QoL information.

Methods

In this multicentre cross-sectional study, patients with schizophrenia have been classified using a hierarchical top-down method called clustering using unsupervised binary trees (CUBT). A three-group structure has been employed to define QoL levels as “high”, “moderate”, or “low”. Socio-demographic, clinical, and QoL data have been compared between the three clusters to ensure their clinical relevance.

Results

A total of 514 patients have been analysed: 78 are classified as “low”, 265 as “moderate”, and 171 as “high”. The clustering shows satisfactory statistical properties, including reproducibility (using bootstrap analysis) and discriminancy (using factor analysis). The three clusters consistently differentiate patients. As expected, individuals in the “high” QoL level cluster report the lowest scores on the Positive and Negative Syndrome Scale (p = 0.01) and the Calgary Depression Scale (p < 0.01), and the highest scores on the Global Assessment of Functioning (p < 0.03), the SF36 (p < 0.01), the EuroQol (p < 0.01), and the Quality of Life Inventory (p < 0.01).

Conclusion

Given the ease with which this method can be applied, classification using CUBT may be useful for facilitating the interpretation of QoL scores in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Awad, A. G., & Voruganti, L. N. (2012). Measuring quality of life in patients with schizophrenia: An update. Pharmacoeconomics, 30(3), 183–195.

    Article  PubMed  Google Scholar 

  2. Bobes, J., Garcia-Portilla, P., Saiz, P. A., Bascaran, T., & Bousono, M. (2005). Quality of life measures in schizophrenia. European Psychiatry, 20(Suppl 3), S313–S317.

    Article  PubMed  Google Scholar 

  3. Cramer, J. A., Rosenheck, R., Xu, W., Thomas, J., Henderson, W., & Charney, D. S. (2000). Quality of life in schizophrenia: A comparison of instruments. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Schizophrenia Bulletin, 26(3), 659–666.

    Article  CAS  PubMed  Google Scholar 

  4. Hayhurst, K. P., Drake, R. J., Massie, J. A., Dunn, G., Barnes, T. R., Jones, P. B., & Lewis, S. W. (2013). Improved quality of life over one year is associated with improved adherence in patients with schizophrenia. European Psychiatry, 29(3), 191–196.

    Article  PubMed  Google Scholar 

  5. Boyer, L., Lancon, C., Baumstarck, K., Parola, N., Berbis, J., & Auquier, P. (2013). Evaluating the impact of a quality of life assessment with feedback to clinicians in patients with schizophrenia: Randomised controlled trial. British Journal of Psychiatry, 202, 447–453.

    Article  PubMed  Google Scholar 

  6. Boyer, L., Millier, A., Perthame, E., Aballea, S., Auquier, P., & Toumi, M. (2013). Quality of life is predictive of relapse in schizophrenia. BMC Psychiatry, 13, 15.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Caqueo-Urizar, A., Gutierrez-Maldonado, J., & Miranda-Castillo, C. (2009). Quality of life in caregivers of patients with schizophrenia: A literature review. Health and Quality of Life Outcomes, 7, 84.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Testart, J., Richieri, R., Caqueo-Urizar, A., Lancon, C., Auquier, P., & Boyer, L. (2013). Quality of life and other outcome measures in caregivers of patients with schizophrenia. Expert Review of Pharmacoeconomics & Outcomes Research, 13(5), 641–649.

    Article  Google Scholar 

  9. Halyard, M. Y., Frost, M. H., & Dueck, A. (2006). Integrating QOL assessments for clinical and research purposes. Current Problems in Cancer, 30(6), 319–330.

    Article  PubMed  Google Scholar 

  10. Halyard, M. Y., Frost, M. H., Dueck, A., & Sloan, J. A. (2006). Is the use of QOL data really any different than other medical testing? Current Problems in Cancer, 30(6), 261–271.

    Article  PubMed  Google Scholar 

  11. Awad, A. G. (2012). Quality-of-life assessment in schizophrenia: The unfulfilled promise. Expert Review of Pharmacoeconomics & Outcomes Research, 11(5), 491–493.

    Article  Google Scholar 

  12. Greenhalgh, J., Long, A. F., & Flynn, R. (2005). The use of patient reported outcome measures in routine clinical practice: Lack of impact or lack of theory? Social Science and Medicine, 60(4), 833–843.

    Article  PubMed  Google Scholar 

  13. Boyer, L., Baumstarck, K., Boucekine, M., Blanc, J., Lancon, C., & Auquier, P. (2013). Measuring quality of life in patients with schizophrenia:an overview. Expert Review of Pharmacoeconomics & Outcomes Research, 13(3), 343–349.

    Article  Google Scholar 

  14. McGorry, P. D., Nelson, B., Goldstone, S., & Yung, A. R. (2010). Clinical staging: A heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Canadian Journal of Psychiatry, 55(8), 486–497.

    Google Scholar 

  15. Lin, A., Reniers, R. L., & Wood, S. J. (2013). Clinical staging in severe mental disorder: Evidence from neurocognition and neuroimaging. British Journal of Psychiatry, Suppl. 54, s11–s17.

    Article  Google Scholar 

  16. Fraiman, F., Ghattas, G., & Svarc, M. (2013). Interpretable clustering using unsupervised binary trees. R package experimental version: CUBT for windows. CUBT for Linux.

  17. Michel, P., Baumstarck, K., Boyer, L., Fernandez, O., Flachenecker, P., Pelletier, J., Loundou, A., Ghattas, B., & Auquier, P. (2014). Defining quality of life levels to enhance clinical interpretation in multiple sclerosis: Application of a novel clustering method. Medical Care.

  18. Boyer, L., Simeoni, M. C., Loundou, A., D’Amato, T., Reine, G., Lancon, C., & Auquier, P. (2010). The development of the S-QoL 18: A shortened quality of life questionnaire for patients with schizophrenia. Schizophrenia Research, 121(1–3), 241–250.

    Article  PubMed  Google Scholar 

  19. APA. (1994). DSM-IV. Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.

    Google Scholar 

  20. CNIL. (2004). Act n°78-17 of 6 January 1978 on Data Processing, Data Files and Individual Liberties (amended by the Act of 6 August 2004 relating to the protection of individuals with regard to the processing of personal data). Journal officiel de la République Française. Assemblée Nationale et Sénat. France.

  21. WMA. (2008). Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. Seoul: World Medical Association, General Assembly.

    Google Scholar 

  22. Kay, S. R., Opler, L. A., & Fiszbein, A. (1986). Significance of positive and negative syndromes in chronic schizophrenia. British Journal of Psychiatry, 149, 439–448.

    Article  CAS  PubMed  Google Scholar 

  23. Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Assessing depression in schizophrenia: The Calgary Depression Scale. British Journal of Psychiatry. Supplement, 22, 39–44.

    Google Scholar 

  24. Endicott, R. L., Spitzer, J. L., & Fleiss, J. C. (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33, 766–771.

    Article  CAS  PubMed  Google Scholar 

  25. Ware, J. E. J., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–483.

    Article  PubMed  Google Scholar 

  26. EuroQoL. (1990). EuroQol—a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy, 16(3), 199–208.

    Article  Google Scholar 

  27. Lehman, A. F. (1983). The well-being of chronic mental patients. Archives of General Psychiatry, 40(4), 369–373.

    Article  CAS  PubMed  Google Scholar 

  28. Lehman, A. F. (1988). A quality of life interview for the chronically mentally ill. Evaluation and program planning, 11, 51–62.

    Article  Google Scholar 

  29. Auquier, P., Simeoni, M. C., Sapin, C., Reine, G., Aghababian, V., Cramer, J., & Lancon, C. (2003). Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: The S-QoL. Schizophrenia Research, 63(1–2), 137–149.

    Article  CAS  PubMed  Google Scholar 

  30. Baumstarck, K., Boyer, L., Boucekine, M., Aghababian, V., Parola, N., Lancon, C., & Auquier, P. (2013). Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment. Schizophrenia Research, 147(1), 58–67.

    Article  PubMed  Google Scholar 

  31. Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984). Classification and regression trees. Monterey: Wadsworth Inc.

    Google Scholar 

  32. Luckett, T., Butow, P. N., & King, M. T. (2009). Improving patient outcomes through the routine use of patient-reported data in cancer clinics: Future directions. Psychooncology, 18(11), 1129–1138.

    Article  CAS  PubMed  Google Scholar 

  33. Boyer, L., Richieri, R., Faget, C., Padovani, R., Vaillant, F., Mundler, O., et al. (2012). Functional involvement of superior temporal sulcus in quality of life of patients with schizophrenia. Psychiatry Research, 202(2), 155–160.

    Article  PubMed  Google Scholar 

  34. Cosci, F., & Fava, G. A. (2013). Staging of mental disorders: Systematic review. Psychotherapy and Psychosomatics, 82(1), 20–34.

    Article  PubMed  Google Scholar 

  35. McKenna, S. P. (1997). Measuring quality of life in schizophrenia. European Psychiatry, 12, 267–274.

    Article  Google Scholar 

  36. Ascher-Svanum, H., Novick, D., Haro, J. M., Aguado, J., & Cui, Z. (2012). Empirically driven definitions of “good,” “moderate,” and “poor” levels of functioning in the treatment of schizophrenia. Quality of Life Research, 22(8), 2085–2094.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T, Jr. (1984). The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10(3), 388–398.

    Article  CAS  PubMed  Google Scholar 

  38. Baraldi, A. N., & Enders, C. K. (2010). An introduction to modern missing data analyses. Journal of School Psychology, 48(1), 5–37.

    Article  PubMed  Google Scholar 

  39. Lipkovich, I. A., Deberdt, W., Csernansky, J. G., Buckley, P., Peuskens, J., Kollack-Walker, S., et al. (2009). Defining “good” and “poor” outcomes in patients with schizophrenia or schizoaffective disorder: A multidimensional data-driven approach. Psychiatry Research, 170(2–3), 161–167.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laurent Boyer.

Appendix: The CUBT procedure

Appendix: The CUBT procedure

The CUBT procedure consists of two stages: growing and tree reduction (i.e. pruning and joining). The clustering tree was built from the eight dimension scores of the SQoL18. The procedure was performed using the data from individuals without missing dimension scores.

The first stage of this method consists of growing a maximal tree from data using a recursive partitioning algorithm. The entire sample is assigned to a root node, which is denoted t. A heterogeneity measure R(t) of the node t, called the deviance, is defined and can be empirically computed as follows:

$$ \hat R\left( t \right) = \frac{{\mathop \sum \nolimits_{\left\{ {{X_i}\; \in \;\hat t} \right\}} {{\left\| {{X_i} - \left. {{{\bar X}_t}} \right\|} \right.}^2}}}{n_t}, $$

where n t is the size of t and \( {\bar X_t} \) is the empirical mean of the observations in t. Let p be the number of variables in the entire sample. For each node t, the best split in two subnodes t l and t r is obtained by defining the couple \( \left( {j,a} \right) \in \left\{ {1, \ldots ,p} \right\} \times {\mathbb{R}} \) (a is a threshold value that could be taken by the variable X j ) that maximises:

$$ \hat \Delta \left( {t,j,a} \right) = \hat R\left( t \right) - \hat R\left( {t_l} \right) - \hat R\left( {t_r} \right). $$

Each new terminal node is then split in this way until one of the two following stopping rules is satisfied. The two stopping rules are defined by fixing the two parameters minsize and mindev. The first rule is satisfied if \( \widehat {\alpha_t} < minsize \) where \( \widehat {\alpha_t} = \frac{n_t}{n},{\text{\;}}{n_t} \) is the size of the node t and n is the size of the entire sample. The second stopping rule is satisfied if the reduction in deviance is less than \( mindev \times \hat \Delta \left( {\mathcal{S},{j_0},{a_0}} \right) \), where \( \mathcal{S} \) is the entire sample and (j 0, a 0) is the best split for the root node. A partition of the data set is obtained, called the maximal tree, in which each leaf represents a cluster.

The second stage (tree reduction) uses two successive algorithms. The first algorithm consists of pruning the tree using a pruning criterion of minimum dissimilarity to reduce the number of clusters. The empirical dissimilarity measure between two adjacent nodes t l and t r is

$$ {d^\delta }\left( {{t_l},{t_r}} \right) = \hbox{max} \left( {\overline {d_l^\delta ,} \overline {d_r^\delta } } \right),$$
$$ \hbox{with }\overline {d_l^\delta ,} = \frac{1}{{\delta {n_l}}}\mathop \sum \limits_{i = 1}^{\delta {n_l}} {d_i} $$
$$ \hbox{and } \overline {d_r^\delta ,} = \frac{1}{{\delta {n_r}}}\mathop \sum \limits_{j = 1}^{\delta {n_r}} {d_j}, $$

where n l and n r are the sizes of t l and t r and δ ∊ [0, 1] is a proportion to address the potential presence of outliers. For each X i  ∊ t l and X j  ∊ t r , d i and d j are the ordered versions of

$$ {\tilde d_l} = {\text {min}}_{x \in {t_r}{\text{\;}}}d\left( {{X_i},x} \right) \hbox{ and } {\tilde d_j} = {\text{mi}}{{\text{n}}_{x \in {t_l}{\text{\;}}}}d\left( {{X_j},x} \right),$$

where d is the Euclidean distance. For the merging criterion, a parameter called mindist is fixed; two adjacent nodes are merged if d δ(t l , t r ) ≤ mindist.

The second algorithm, the joining step, consists of aggregating the leaves of the tree, even if they do not share the same direct ascendant, using the same criterion as that used in the pruning step. The following two stopping criteria can be considered: (1) the number of expected clusters k is obtained or (2) a fixed threshold value η (that must be specified) is reached by d δ(t l , t r ).

To define a stopping criterion for the algorithm, we considered a three-group structure of QoL clusters to simplify the interpretability of the partition. Pairs of terminal nodes (constrained to 50 observations) were successively aggregated, producing one less cluster at each step until three clusters remained. Other scenarios were performed by varying the number of final clusters (4, 5, and 6) and the minimum number of observations by the terminal node (25, 100, and 200).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Michel, P., Auquier, P., Baumstarck, K. et al. How to interpret multidimensional quality of life questionnaires for patients with schizophrenia?. Qual Life Res 24, 2483–2492 (2015). https://doi.org/10.1007/s11136-015-0982-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-015-0982-y

Keywords

Navigation